Sign in

CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company

Phio Pharmaceuticals Corp.

Sign in to watch
Ticker
PHIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453215903
Phone
(508) 767-3861
Business address
411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
Former names
RXi Pharmaceuticals Corp
  1. 4 Grant or award Director acquired 18,500 shares (grant or award)
  2. 4 Grant or award Chairman, Pres. & CEO acquired 120,000 shares (grant or award)
  3. 4 Open-market buy Chairman, Pres. & CEO bought 5,000 shares at $1.03 ($5,150)
  4. 4 Open-market buy Chairman, Pres. & CEO bought 5,000 shares at $1.02 ($5,100)
  5. 4 Open-market buy Chairman, Pres. & CEO bought 5,000 shares at $1.14 ($5,700)
  6. 4 Open-market buy Chairman, Pres. & CEO bought 5,000 shares at $1.27 ($6,350)
  7. 4/A Grant or award Director acquired 23,100 shares (grant or award)
  8. 4 Grant or award Director acquired 14,000 shares (grant or award)
  9. 4 Grant or award Director acquired 16,200 shares (grant or award)
  10. 4 Grant or award Director acquired 14,700 shares (grant or award)
  11. 4 Grant or award Director acquired 23,000 shares (grant or award)
  12. 4 Grant or award VP, Finance and Administration acquired 47,000 shares (grant or award)
  13. 4 Grant or award Director acquired 18,800 shares (grant or award)
  14. 4 Shares withheld for taxes Chairman, Pres. & CEO gave up 4,111 shares (to pay taxes)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Chairman, Pres & CEO bought 2,000 shares at $2.42 ($4,840)
  17. 4 Open-market buy Director bought 2,500 shares at $2.42 ($6,050)
  18. 4 Open-market buy Chairman, Pres & CEO bought 1,500 shares at $2.75 ($4,125)
  19. 4 Open-market buy Chairman, Pres & CEO bought 4,200 shares at an average $1.77 ($7,446)
  20. 4 Open-market buy Director bought 2,500 shares at $1.82 ($4,550)

Page 2 of 15 · 281 filings